Development of Pharmaceutical Additives-Evaluation of Protein and Polysaccharide Hydrolysates as Carrier to Enhance Absorption Rate of Drug

药物添加剂的开发-蛋白质和多糖水解物作为载体提高药物吸收率的评价

基本信息

  • 批准号:
    07557146
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1997
  • 项目状态:
    已结题

项目摘要

Protein and polysaccharides such as water-soluble gelatin, egg albumin, casein hydrolysate, low molecular chitosan and alginate are the preferred carriers of drugs in various pharmaceutical formulations. However, improvents of the dissolution and absorption of drugs using natural polymers have been not fully studied. Thus, the present study was undertaken to investigate the possible use of natural polymers such as casein hydrolysate, egg albumin as solubilizing agents to improve the absorption of poorly water soluble drugs. The results obtained here are summarized as follows :1)Two types of fragmented keratin (FKs) were prepared from buffalo horn and hoof using savinase and Na_2S,and their physicochemical and biopharmaceutical properties were examined in mice. The systematic acute toxicity of FKs was significantly lower than that of superoxide dismutase. In plasma, enzymatically fragmented keratin was hydrolyzed slowly, but in liver and kidney homogenates it showed slightly faster hydr … More olysis. In contrast, fragmented gelatin was not hydrolyzed in any of the media used here.2)The solubility of dl-a-tocopherol (VE) was increased by 300-fold in the presence of egg albumin. The apparent dissolution rate of VE from solid dispersion with egg albumin was markedly enhanced in comparison with VE alone. The mean serum levels of VE following oral administration of egg albumin solid dispersions, especially egg albumin solid dispersion containing myristic acid, were significantly higher than those of the drug alone.3)Two types of casein hydrolysates, casein A (mean peptide length 3.3) and casein B (mean peptide length 17.4) were prepared by the enzymatic hydrolysis of casein, and their effects on in vitro dissolution rates and oral bioavailability of drugs were evaluated. The in vitro dissolution behavior of the kneaded mixture of three drugs (diclofenac acid, diazepam, and prednisolone) with caseins A and B were significantly improved compared to the drugs alone. The plasma concentration-time profile showed that prednisolone was completely and rapidly absorbed from the casein A kneaded mixture as well as the prednisolone solution. In addition, prednisolone in the kneaded mixture with casein B was more difficult to absorb up to 1 hr after administration in comparison to prednisolone powder. Less
蛋白质和多糖如水溶性明胶、蛋清蛋白、酪蛋白水解物、低分子壳聚糖和海藻酸盐是各种药物制剂中首选的药物载体。然而,使用天然聚合物改善药物的溶出和吸收还没有得到充分的研究。因此,本研究旨在探讨酪蛋白水解物、蛋清蛋白等天然聚合物作为增溶剂改善难溶药物吸收的可能性。1)利用腐植酸酶和Na2S从水牛的角和蹄中制备了两种碎裂角蛋白(FKS),并考察了它们在小鼠体内的理化和生物药理性质。FKS的全身急性毒性明显低于超氧化物歧化酶。在血浆中,酶解角蛋白的速度很慢,但在肝和肾的匀浆中,它的Hydr…略快一些。更多的溶解。相反,碎裂的明胶在所用的任何介质中都没有被水解。2)在蛋清的存在下,dl-a-生育酚(VE)的溶解度增加了300倍。卵白蛋白固体分散体中VE的表观溶出度明显高于单独VE。口服蛋清蛋白固体分散体,尤其是含有肉豆蔻酸的蛋清蛋白固体分散体后,VE的平均血药浓度显著高于单独给药。3)用酶解酪蛋白制备了酪蛋白A(平均肽长3.3)和酪蛋白B(平均肽长17.4)两种酪蛋白水解物,并考察了它们对药物体外溶出度和口服生物利用度的影响。三种药物(双氯芬酸、安定、强的松龙)与酪蛋白A、B混合捏合后的体外溶出行为较单用药物显著改善。血药浓度-时间曲线表明,强的松龙在酪蛋白A捏合液和强的松龙溶液中均能迅速完全吸收。此外,与强的松龙粉相比,强的松龙与酪蛋白B捏合的混合物在给药后1小时内更难被吸收。较少

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
今井 輝子、小田切 優樹(他3名): "Casein Hydrolysate as a Rapid and/or Enteric Dissoluing Additive for Oral Drugs" Pharmaceutical Development and Technology. 3.2(in press). (1998)
Teruko Imai、Yuki Odagiri(以及其他 3 人):“酪蛋白水解物作为口服药物的快速和/或肠溶添加剂”药物开发和技术 3.2(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Otagiri Masaki et al: "Casein Hydrolysate as a Rapid and / or Enteric Dissoluing Additive for Oral Drugs" Pharmaceutical Development and Technology. 3.2. (1998)
Otagiri Masaki 等人:“酪蛋白水解物作为口服药物的快速和/或肠溶添加剂”药物开发和技术。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
今井輝子,小田切優樹(他4名): "Mutual Effect of Egg Albuin and Fatty Acid on Bioacaility of dl-α-Tocopherol" Int.J.Pharm.(1997)
Teruko Imai、Yuki Odagiri(以及其他 4 人):“鸡蛋白蛋白和脂肪酸对 dl-α-生育酚生物活性的相互影响”Int.J.Pharm.(1997)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Fathy、小田切 優樹(他3名): "Preparation and Evaluation of Beads of Different Calcium Alginate Composition for Oral Sustained Relase of Tiaramide" Pharmaceutical Development and Technology. (in press). (1998)
M.Fathy、Yuki Odagiri(以及其他 3 人):“用于 Tiaramide 口服持续释放的不同海藻酸钙组合物的制备和评估”药物开发和技术(1998 年出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Kida,M.Otagiri (他4名): "Enzymatic hydrolysis of the horn and hoof of cow and buffalo" J.Ferment.Bioeng.80. 478-484 (1995)
K.Kida、M.Otagiri(其他 4 人):“牛和水牛的角和蹄的酶水解”J.Ferment.Bioeng.80 478-484 (1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OTAGIRI Masaki其他文献

OTAGIRI Masaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OTAGIRI Masaki', 18)}}的其他基金

Development of novel hybrid anti-oxidant based on albumin fusion technology and its therapeutic application on acute radiation syndrome
基于白蛋白融合技术的新型混合抗氧化剂的研制及其在急性放射综合征治疗中的应用
  • 批准号:
    15K15008
  • 财政年份:
    2015
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Construction of an Innovative Bone Marrow Delivery System of Anticancer Drug for Control of Malignant Tumors' Bone Metastasis
构建创新的抗癌药物骨髓输送系统以控制恶性肿瘤骨转移
  • 批准号:
    25670085
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Design and Evaluation of Next Generation Albumin-thioredoxin Fusion Protein for Multiple Organ Failure Treatment
用于多器官衰竭治疗的下一代白蛋白-硫氧还蛋白融合蛋白的设计和评估
  • 批准号:
    24390043
  • 财政年份:
    2012
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of effective blood purification treatment method usingHSA bound toxic comnpodus designed bpyhase display tecnohlogy
利用HSA结合有毒化合物设计的bpyhase显示技术开发有效的血液净化治疗方法
  • 批准号:
    23659088
  • 财政年份:
    2011
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of Redox Controlling Nanomedicine Based on Albumin Fusion
基于白蛋白融合的氧化还原控制纳米药物的开发
  • 批准号:
    21390177
  • 财政年份:
    2009
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Application of functional recombinant HSAs as a DDS carrier
功能性重组HSAs作为DDS载体的应用
  • 批准号:
    18390051
  • 财政年份:
    2006
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The development of next-generation albumin preparation by mutagenesi s studies
诱变研究开发下一代白蛋白制剂
  • 批准号:
    14370759
  • 财政年份:
    2002
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Design and Evaluation of Albumin Mutants for Clinical Application
临床应用白蛋白突变体的设计和评价
  • 批准号:
    11694298
  • 财政年份:
    1999
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Design and Functional Evaluation of Albumin Mutants for Improving Medicinal Efficacy
提高药效的白蛋白突变体的设计和功能评价
  • 批准号:
    10557245
  • 财政年份:
    1998
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Topology Analysis of Drug Binding Sites on Serum Proteins using Photoaffinity Labeling Techniques
使用光亲和标记技术对血清蛋白上的药物结合位点进行拓扑分析
  • 批准号:
    09470505
  • 财政年份:
    1997
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Novel liquid embolic materials for brain endovascular therapy: natural polymer composite activated by blood calcium ions
用于脑血管内治疗的新型液体栓塞材料:血钙离子激活的天然高分子复合材料
  • 批准号:
    17H02080
  • 财政年份:
    2017
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: A Natural Polymer-Based Engineered Red Blood Cell Product
I-Corps:一种基于天然聚合物的工程红细胞产品
  • 批准号:
    1644585
  • 财政年份:
    2016
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Standard Grant
Natural polymer scaffolds and gene-loaded nanoparticles for tissue engineering
用于组织工程的天然聚合物支架和基因负载纳米粒子
  • 批准号:
    386361-2010
  • 财政年份:
    2014
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
Natural polymer scaffolds and gene-loaded nanoparticles for tissue engineering
用于组织工程的天然聚合物支架和基因负载纳米粒子
  • 批准号:
    386361-2010
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
I-Corps: Natural Polymer Based Systems for Bone Repair and Regeneration
I-Corps:基于天然聚合物的骨骼修复和再生系统
  • 批准号:
    1355327
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Standard Grant
Study on the mechanisms of crosslinking of natural polymer by ionizing radiation
天然高分子电离辐射交联机理研究
  • 批准号:
    25871093
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
AIR Option 2: Research Allianace Polymer, Polymer-Ceramic and Natural Polymer Based Systems for Soft Tissue and Bone Repair and Regeneration
AIR 选项 2:研究 Allianace 聚合物、聚合物陶瓷和天然聚合物系统,用于软组织和骨骼修复与再生
  • 批准号:
    1311907
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Standard Grant
Natural polymer scaffolds and gene-loaded nanoparticles for tissue engineering
用于组织工程的天然聚合物支架和基因负载纳米粒子
  • 批准号:
    386361-2010
  • 财政年份:
    2012
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
Natural polymer scaffolds and gene-loaded nanoparticles for tissue engineering
用于组织工程的天然聚合物支架和基因负载纳米粒子
  • 批准号:
    386361-2010
  • 财政年份:
    2011
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Discovery Grants Program - Individual
RAPID: Water-based, Natural Polymer Surfactants: Implications for Deepwater Horizon Oil Spill Dispersions
RAPID:水基天然聚合物表面活性剂:对深水地平线溢油分散体的影响
  • 批准号:
    1057897
  • 财政年份:
    2010
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了